The conference provides an opportunity to learn from international experts about the latest evidence and clinical approaches in recurrent pregnancy loss, fertility, IVF, ART, reproductology, and human reproduction. The program covers RPL diagnosis and risk prediction, thyroid disorders and recurrent miscarriage, ovarian stimulation and endocrine monitoring, adenomyosis and uterine factors in IVF, endometrial receptivity and progesterone responsiveness, reproductive immunology and inflammation, including KIR/HLA and euploid pregnancy loss, as well as treatment strategies such as IVIG and Tacrolimus. Participants will also explore the role of the reproductive microbiome, early pregnancy loss, and patient-centred and trauma-informed care, with insights into current research and clinical practice